1. Hanahan, D, Weinberg, RA. Hallmarks of cancer: The next generation. Cell. 2011;144:646-674.
Google Scholar | Crossref | Medline | ISI2. DeNardo, DG, Andreu, P, Coussens, LM. Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev. 2010;29:309-316.
Google Scholar | Crossref | Medline | ISI3. Egeblad, M, Nakasone, ES, Werb, Z. Tumors as organs: Complex tissues that interface with the entire organism. Develop Cell. 2010;18:884-901.
Google Scholar | Crossref | Medline | ISI4. Qian, B-Z, Pollard, JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141:39-51.
Google Scholar | Crossref | Medline | ISI5. Murdoch, C, Muthana, M, Coffelt, SB, Lewis, CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer. 2008;8:618-631.
Google Scholar | Crossref | Medline | ISI6. Galdiero, MR, Marone, G, Mantovani, A. Cancer inflammation and cytokines. Cold Spring Harbor Perspect Biol 2018;10(8), a028662.
Google Scholar7. deVisser, KE, Eichten, A, Coussens, LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6:24-37.
Google Scholar | Crossref | Medline8. Diakos, CI, Charles, KA, McMillan, DC, Clarke, SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493-e503.
Google Scholar | Crossref | Medline9. Dolan, RD, Laird, BJA, Horgan, PG, McMillan, DC. The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: A systematic review. Crit Rev Oncol Hematol. 2018;132:130-137.
Google Scholar | Crossref | Medline10. Templeton, AJ, Ace, O, McNamara, MG, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: A systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2014;23:1204-1212.
Google Scholar | Crossref | Medline | ISI11. Guthrie, GJK, Charles, KA, Roxburgh, CSD, Horgan, PG, McMillan, DC, Clarke, SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88:218-230.
Google Scholar | Crossref | Medline | ISI12. Basile, D, Garattini, SK, Corvaja, C, et al. The MIMIC Study: Prognostic role and cutoff definition of monocyte‐to‐lymphocyte ratio and lactate dehydrogenase levels in metastatic colorectal cancer. Oncologist. 2020;25:661-668.
Google Scholar | Crossref | Medline13. Qi, Q, Zhuang, L, Shen, Y, et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer. 2016;122:2158-2167.
Google Scholar | Crossref | Medline14. Xu, L, Yu, S, Zhuang, L, et al. Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients. Oncotarget. 2017;8:34954-34960.
Google Scholar | Crossref | Medline15. Li, S, Lan, X, Gao, H, et al. Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection. J Cancer Res Clin Oncol. 2017;143:2455-2468.
Google Scholar | Crossref | Medline16. Gu, L, Ma, X, Wang, L, et al. Prognostic value of a systemic inflammatory response index in metastatic renal cell carcinoma and construction of a predictive model. Oncotarget. 2017;8:52094-52103.
Google Scholar | Crossref | Medline17. Geng, Y, Zhu, D, Wu, C, et al. A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma. Int Immunopharm. 2018;65:503-510.
Google Scholar | Crossref | Medline18. Chen, Y, Jiang, W, Xi, D, et al. Development and validation of nomogram based on SIRI for predicting the clinical outcome in patients with nasopharyngeal carcinomas. J Invest Med. 2019;67:691-698.
Google Scholar | Crossref | Medline19. Chen, Y, Jin, M, Shao, Y, Xu, G. Prognostic value of the systemic inflammation response index in patients with adenocarcinoma of the oesophagogastric junction: A propensity score-matched analysis. Dis Markers. 2019;2019:4659048.
Google Scholar | Crossref | Medline20. Li, S, Yang, Z, Du, H, et al. Novel systemic inflammation response index to predict prognosis after thoracoscopic lung cancer surgery: a propensity score-matching study. ANZ J Surg. 2019;89:E507-E513.
Google Scholar | Crossref | Medline21. Zheng, Y, Chen, Y, Chen, J, et al. Combination of systemic inflammation response index and platelet-to-lymphocyte ratio as a novel prognostic marker of upper tract urothelial Carcinoma after radical Nephroureterectomy. Front Oncol. 2019;9:914.
Google Scholar | Crossref | Medline22. Zhang, Y, Liu, F, Wang, Y. Evidence of the prognostic value of pretreatment systemic inflammation response index in cancer patients: A pooled analysis of 19 cohort studies. Dis Markers. 2020;2020:8854267.
Google Scholar | Crossref | Medline23. Lin, J, Chen, L, Chen, Q, et al. Prognostic value of preoperative systemic inflammation response index in patients with oral squamous cell carcinoma: Propensity score-based analysis. Head Neck; 2020;42(11):3263-3274.
Google Scholar | Crossref | Medline24. Sun, L, Hu, W, Liu, M, et al. High Systemic Inflammation Response Index (SIRI) indicates poor outcome in gallbladder cancer patients with surgical resection: A Single institution experience in China. Cancer Res Treat; 2020;52(4):1199-1210.
Google Scholar | Medline25. Chen, L, Kong, X, Wang, Z, Wang, X, Fang, Y, Wang, J. Pretreatment systemic inflammation response index in patients with breast cancer treated with neoadjuvant chemotherapy as a useful prognostic indicator. Cancer Manag Res. 2020;12:1543-1567.
Google Scholar | Crossref | Medline26. Chao, B, Ju, X, Zhang, L, Xu, X, Zhao, Y. A novel prognostic marker Systemic Inflammation Response Index (SIRI) for operable cervical cancer patients. Front Oncol. 2020;10:766.
Google Scholar | Crossref | Medline27. Zeng, X, Liu, G, Pan, Y, Li, Y. Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma. J Cell Mol Med. 2020;24:8326-8349.
Google Scholar | Crossref | Medline28. Liberati, A, Altman, DG, Tetzlaff, J, et al., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
Google Scholar | Crossref | Medline29. Higgins, JPT, Altman, DG, Gotzsche, PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
Google Scholar | Crossref | Medline30. Zhou, S, Yuan, H, Wang, J, et al. Prognostic value of systemic inflammatory marker in patients with head and neck squamous cell carcinoma undergoing surgical resection. Future Oncol. 2020;16:559-571.
Google Scholar | Crossref | Medline31. YesilCinkir, H, Elboga, U. The effect of systemic inflammation indexes and 18FDG PET metabolic parameters on survival in advanced lung adenocarcinoma. Tumori J. 2020;106:312-318.
Google Scholar | SAGE Journals32. YeşilÇinkir, H, ÇolakoğluEr, H. The prognostic effects of temporal muscle thickness and inflammatory-nutritional parameters on survival in lung cancer patients with brain metastasis. Turk Onkoloji Dergisi. 2020;35:119-126.
Google Scholar33. Wang, L, Zhou, Y, Xia, S, et al. Prognostic value of the systemic inflammation response index (SIRI) before and after surgery in operable breast cancer patients. Cancer Biomarkers. 2020;28:537-547.
Google Scholar | Crossref | Medline34. Topkan, E, Mertsoylu, H, Kucuk, A, et al. Low systemic inflammation response index predicts good prognosis in locally advanced pancreatic carcinoma patients treated with concurrent chemoradiotherapy. Gastroenterol Res Pract. 2020;2020:5701949.
Google Scholar | Crossref | Medline35. Pacheco-Barcia, V, MondéjarSolís, R, France, T, et al. A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer. Pancreatology. 2020;20:254-264.
Google Scholar | Crossref | Medline36. Li, S, Xu, H, Wang, W, et al. The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma. Cancer Manag Res. 2019;11:3327-3337.
Google Scholar | Crossref | Medline37. Hua, X, Long, Z-Q, Huang, X, et al. The preoperative systemic inflammation response index (SIRI) independently predicts survival in postmenopausal women with breast cancer. Curr Probl Cancer. 2020;44:100560.
Google Scholar | Crossref | Medline38. Hu, M, Xu, Q, Yang, S, et al. Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: A two-center retrospective study. Ann Transl Med. 2020;8:1310.
Google Scholar | Crossref | Medline39. Gao, W, Zhang, F, Ma, T, Hao, J. High preoperative fibrinogen and systemic inflammation response index (F-SIRI) predict unfavorable survival of resectable gastric cancer patients. J Gastr Cancer. 2020;20:202-211.
Google Scholar | Crossref | Medline40. Feng, Y, Zhang, N, Wang, S, et al. Systemic inflammation response index is a predictor of poor survival in locally advanced nasopharyngeal carcinoma: A propensity score matching study. Front Oncol. 2020;10:575417.
Google Scholar | Crossref | Medline41. Çınkır, HY, Doğan, İ. Comparison of inflammatory indexes in patients treated with sorafenib in advanced hepatocellular carcinoma: A single-center observational study. Erciyes Med J. 2020;42:201-206.
Google Scholar42. Chuang, H-C, Tsai, M-H, Lin, Y-T, et al. The clinical impacts of pretreatment peripheral blood ratio on lymphocytes, monocytes, and neutrophils among patients with laryngeal/hypopharyngeal cancer treated by chemoradiation/radiation. Cancer Manag Res. 2020;12:9013-9021.
Google Scholar | Crossref | Medline43. Chen, Z, Wang, K, Lu, H, et al. Systemic inflammation response index predicts prognosis in patients with clear cell renal cell carcinoma: A propensity score-matched analysis. Cancer Manag Res. 2019;11:909-919.
Google Scholar | Crossref | Medline44. Topkan, E, Kucuk, A, Ozdemir, Y, et al. Systemic inflammation response index predicts survival outcomes in glioblastoma multiforme patients treated with standard stupp protocol. J Immunol Res. 2020;2020:8628540.
Google Scholar | Crossref | Medline45. Kucuk, A, Ozkan, EE, EskiciOztep, S, et al. The influence of systemic inflammation response index on survival outcomes of limited-stage small-cell lung cancer patients treated with concurrent chemoradiotherapy. J Oncol. 2020;2020:8832145.
Google Scholar | Crossref | Medline46. Kobayashi, H, Okuma, T, Okajima, K, et al. Systemic inflammation response index (SIRI) as a predictive factor for overall survival in advanced soft tissue sarcoma treated with eribulin. J Orthop Sci. 2020;2658(20):30346-30348.
Google Scholar47. Wei, L, Xie, H, Yan, P. Prognostic value of the systemic inflammation response index in human malignancy. Medicine. 2020;99:e23486.
Google Scholar | Crossref | Medline48. Qu, X, Tang, Y, Hua, S. Immunological approaches towards cancer and inflammation: A cross talk. Front Immunol. 2018;9:563.
Google Scholar | Crossref | Medline49. Granot, Z, Jablonska, J. Distinct functions of neutrophil in cancer and its regulation. Mediat Inflamm. 2015;2015:701067.